GSDMD and neoplasm: Conversely, GSDMD protein levels were remarkably increased in non-small cell lung cancer (NSCLC) compared to adjacent controls and were associated with greater tumor size, more advanced tumor node metastasis stages, and, in lung adenocarcinoma (LUAD), poorer prognosis [27].